Advertisement

Martin Shkreli

Latest Stories

The Supreme Court is seen on Monday, Oct. 7, 2024, in Washington. (AP Photo/Mariam Zuhaib)

Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli

By Lindsay Whitehurst - Associated Press

FILE - The Supreme Court is pictured, June 30, 2024, in Washington. (AP Photo/Susan Walsh)

Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli

By Lindsay Whitehurst - Associated Press

Martin Shkreli gives an interview on the Fox Business Network in New York, Aug. 15, 2017. (AP Photo/Richard Drew, File)

Judge orders ‘Pharma Bro’ Martin Shkreli to turn over all copies of unreleased Wu-Tang Clan album

By Larry Neumeister - Associated Press

Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016. Shkreli has been freed from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company. (AP Photo/Susan Walsh, File)

Appeals court bans ‘Pharma Bro’ Martin Shkreli from working in pharmaceuticals ever again

By Brad Matthews - The Washington Times

Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016. Shkreli has been freed from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company. (AP Photo/Susan Walsh, File)

‘Pharma Bro’ Martin Shkreli freed from prison, transferred to halfway house

By Larry Neumeister - Associated Press

Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016. A federal judge on Friday, Jan. 14, 2022 ordered Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. (AP Photo/Susan Walsh, File)

Shkreli ordered to return $64M, is barred from drug industry

By Michael R. Sisak and Jennifer Peltz - Associated Press

Pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington, on Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Vyera Pharmaceuticals, a company once owned by Shkreli, will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug. The Federal Trade Commission announced the settlement Tuesday, Dec. 7, 2021. (AP Photo/Susan Walsh, File)

‘Pharma Bro’ firm reaches $40M settlement in gouging case

Associated Press

FILE - In this Aug. 3, 2017, file photo, Martin Shkreli arrives at federal court in New York. A federal judge has rejected convicted pharmaceutical executive's Martin Shkreli's second request to be let out of prison early, Tuesday, Jan. 19, 2021, showing skepticism about his claim in court papers that mental health issues have weakened his immune system and made him more susceptible to contracting the coronavirus.(AP Photo/Seth Wenig, File)

‘Pharma Bro’ Shkreli loses 2nd bid for early prison release

By MICHAEL R. SISAK - Associated Press

‘Delusional’ Martin Shkreli denied prison release by judge

Associated Press

‘Pharma Bro’ wants out of prison to research coronavirus

By TOM HAYS - Associated Press

In this Aug. 4, 2017, file photo, Martin Shkreli leaves federal court in New York while on trial for deceiving investors in a pair of failed hedge funds. On Monday, Jan. 27, 2020, New York state and federal authorities sued the imprisoned Shkreli, also known as &quot;Pharma Bro,&quot; over business tactics that helped make him the bad-boy face of profiteering in pharmaceuticals, seeking to bar him from the industry for life. (AP Photo/Seth Wenig, File)

N.Y., feds sue ‘Pharma Bro’ for ‘scheme’ to keep drug price up

By Jennifer Peltz - Associated Press

FILE- In this Aug. 15, 2017 file photo, former pharmaceutical CEO Martin Shkreli speaks during an interview by Maria Bartiromo during her &quot;Mornings with Maria Bartiromo&quot; program on the Fox Business Network, in New York. The imprisoned pharmaceutical entrepreneur, who is serving prison time for fraud, has filed a fraud lawsuit against one of his former investors. (AP Photo/Richard Drew, File)

Ex-drug company CEO Martin Shkreli sues former investor

By TOM HAYS - Associated Press

The Latest: Shkreli lawyer disappointed by upheld conviction

Associated Press

FILE - In this Thursday, July 27, 2017, file photo, Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, in New York. A federal appeals court on Thursday, July 18, 2019 has upheld the securities fraud conviction against the former drug company CEO. (AP Photo/Julie Jacobson, File)

Court upholds ‘Pharma Bro’ Martin Shkreli’s conviction

Associated Press

FILE - In this Aug. 15, 2017 file photo, Martin Shkreli is interviewed by Maria Bartiromo during her &quot;Mornings with Maria Bartiromo&quot; program on the Fox Business Network, in New York. A federal appeals court in New York City is considering whether the securities fraud conviction against Shkreli, the former drug company executive known as “Pharma Bro” should be thrown out. An attorney Shkreli urged the court to overturn a 2017 guilty verdict for Shkreli, claiming the trial judge gave confusing instructions to the jury about the law. A prosecutor insisted the instructions were proper. (AP Photo/Richard Drew, File)

Court hears appeal on ‘Pharma Bro’ Shkreli’s fraud case

Associated Press

"The reason why you want to invest in the generic drug sector is because there is the opportunity to substantially lower the cost of manufacturing and at the same time increase quality," said Fernando Muzzio, a Rutgers University chemical and biochemical engineering professor who participated Wednesday in a panel discussion on generic drugs on Capitol Hill. (AP Photo/Rick Bowmer, File)

The trouble with generic drugs

By Jared Whitley

‘Pharma Bro’ Martin Shkreli sues over ouster from company

Associated Press

‘Pharma Bro’ in solitary confinement for alleged phone use

By MICHAEL R. SISAK and JIM MUSTIAN - Associated Press

FILE - In this June 19, 2017, file photo, former Turing Pharmaceuticals CEO Martin Shkreli, center, arrives at Brooklyn federal court in New York with members of his legal team. Federal authorities are investigating claims that Shkreli has been running his pharmaceutical company from behind bars. The U.S. Bureau of Prisons said Friday, March 8, 2019, that it has opened an inquiry into whether the so-called &quot;Pharma Bro&quot; used a contraband smartphone inside a federal prison in New jersey. (AP Photo/Mark Lennihan, File)

Feds probe alleged prison cellphone use by ‘Pharma Bro’

By JIM MUSTIAN - Associated Press

Lawsuit: ‘Pharma Bro’ ruined career in targeted campaign

Associated Press